Amgen Inc.
AMGN
$369.53
$1.930.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.47% | 12.10% | 9.08% | 10.61% | 11.27% |
| Total Other Revenue | 34.86% | 19.32% | 17.58% | -16.11% | 1.93% |
| Total Revenue | 8.58% | 12.40% | 9.43% | 9.43% | 10.86% |
| Cost of Revenue | -1.33% | 3.59% | 3.73% | 3.91% | 10.42% |
| Gross Profit | 12.80% | 16.38% | 11.96% | 12.23% | 11.05% |
| SG&A Expenses | 3.94% | 5.85% | -5.27% | -6.69% | 5.09% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -52.33% | -200.00% | 153.54% | -18.92% | 122.11% |
| Total Operating Expenses | 5.64% | 8.59% | 8.70% | 1.98% | 29.75% |
| Operating Income | 15.92% | 20.53% | 10.97% | 33.62% | -18.67% |
| Income Before Tax | 93.61% | 26.44% | 97.48% | 3,001.47% | -8.22% |
| Income Tax Expenses | 16.77% | 160.15% | 183.33% | 440.00% | 82.35% |
| Earnings from Continuing Operations | 112.60% | 13.64% | 91.96% | 1,630.97% | -18.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 112.60% | 13.64% | 91.96% | 1,630.97% | -18.25% |
| EBIT | 15.92% | 20.53% | 10.97% | 33.62% | -18.67% |
| EBITDA | 3.50% | 11.38% | 5.79% | 18.31% | -12.44% |
| EPS Basic | 111.81% | 13.43% | 91.60% | 1,625.43% | -18.55% |
| Normalized Basic EPS | 30.40% | 32.94% | 27.68% | 46.66% | -17.50% |
| EPS Diluted | 112.06% | 13.60% | 92.03% | 1,618.03% | -18.73% |
| Normalized Diluted EPS | 30.64% | 33.18% | 27.91% | 45.85% | -17.50% |
| Average Basic Shares Outstanding | 0.37% | 0.19% | 0.19% | 0.37% | 0.37% |
| Average Diluted Shares Outstanding | 0.18% | 0.00% | 0.00% | 0.93% | 0.37% |
| Dividend Per Share | 5.78% | 5.78% | 5.78% | 5.78% | 5.63% |
| Payout Ratio | -0.50% | -0.07% | -0.45% | 1.07% | 0.29% |